Iovance Biotherapeutics (IOVA) Gross Profit Growth (1y) (2024 - 2026)

Iovance Biotherapeutics (IOVA) Gross Profit Growth (1y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Profit Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	11.24%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.59%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	68.41%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	33.01%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-41.93%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	57.16%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	351.57%
10	Iovance Biotherapeutics	3.16 Bn	2.86 Bn	55.72 Mn	403.28%

Download Data